Cleared Traditional

K991828 - STREP B OIA

K991828 is an FDA 510(k) clearance for STREP B OIA, manufactured by Biostar, Inc.. The device is a Class 1 Microbiology device with product code GTY cleared through the Traditional 510(k) pathway after a 83-day FDA review.

K991828 · Biostar, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1999
Decision
83d
Days
Class 1
Risk

K991828 is an FDA 510(k) clearance for the STREP B OIA. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.

Submitted by Biostar, Inc. (Boulder, US). The FDA issued a Cleared decision on August 19, 1999 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biostar, Inc. devices

FDA 510(k) Submission Details - K991828

510(k) Number K991828 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 1999
Decision Date August 19, 1999
Days to Decision 83 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 102d · This submission: 83d
Pathway characteristics
Predicate-based equivalence.

GTY Device Classification - Class 1, General Controls

Product Code GTY Antigens, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTY Antigens, All Groups, Streptococcus Spp.

All 36
Devices cleared under the same product code (GTY) and FDA review panel - the closest regulatory comparables to K991828.
SAS STREPALERT
K013379 · Sa Scientific, Inc. · Dec 2001
QUICKVUE DIPSTICK STREP A
K011097 · Quidel Corp. · May 2001
SAS STREP A TEST
K993456 · Sa Scientific, Inc. · Mar 2000
UNI-GOLD STREP A TEST KIT
K982373 · Trinity Biotech, Plc · Feb 1999
BIOSTREP A-DIRECT STREP A ANTIGEN TEST
K983386 · Princeton BioMeditech Corp. · Nov 1998
BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST
K971349 · Princeton BioMeditech Corp. · Jul 1997